Newly Identified Tree Shrew 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog 2A13 and Pig 2A19.

Drug Metab Dispos

Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (G.U., Y.U.); Showa Pharmaceutical University, Tokyo, Japan (Y.N., N.M., H.Y.); School of Veterinary Medicine, Kitasato University, Aomori, Japan (H.K.); and Transboundary Animal Diseases Center and Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan (K.T.-K.)

Published: May 2023

The tree shrew, a non-rodent primate-like species, is used in various fields of biomedical research, including hepatitis virus infection, myopia, depression, and toxicology. Recent genome analysis found that the numbers of cytochrome P450 (P450 or ) genes are similar in tree shrews and humans and their sequence identities are high. Although the P450s are a family of important drug-metabolizing enzymes, they have not yet been fully investigated in tree shrews. In the current study, tree shrew CYP2A13 cDNA was isolated from liver, and its characteristics were compared with those of pig, dog, and human CYP2As. Tree shrew CYP2A13 amino acid sequences were highly identical (87-92%) to the human CYP2As and contained sequence motifs characteristic of P450s. Phylogenetic analysis revealed that tree shrew CYP2A13 was more closely related to human CYP2As than to rat CYP2As, similar to dog and pig CYP2As. Among the tissue types analyzed, tree shrew CYP2A13 mRNA was preferentially expressed in liver and lung, similar to dog CYP2A13 mRNA, whereas dog CYP2A25 and pig CYP2A19 mRNAs were predominantly expressed in liver. Tree shrew liver microsomes and tree shrew CYP2A13 proteins heterologously expressed in Escherichia coli catalyzed coumarin 7-hydroxylation and phenacetin -deethylation, just as human, dog, and pig CYP2A proteins and liver microsomes do. These results demonstrate that tree shrew is expressed in liver and lung and encodes a functional drug-metabolizing enzyme. SIGNIFICANCE STATEMENT: Novel tree shrew cytochrome P450 2A13 (CYP2A13) was identified and characterized in comparison with human, dog, and pig CYP2As. Tree shrew CYP2A13 isolated from liver had high sequence identities and close phylogenetic relationships to its human homologs and was abundantly expressed in liver and lung at the mRNA level. Tree shrew CYP2A13 metabolized coumarin and phenacetin, human selective CYP2A6 and CYP2A13 substrates, respectively, similar to dog and pig CYP2As, and is a functional drug-metabolizing enzyme likely responsible for drug clearances.

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.122.001152DOI Listing

Publication Analysis

Top Keywords

tree shrew
48
shrew cyp2a13
28
expressed liver
20
liver lung
16
dog pig
16
tree
14
shrew
12
functional drug-metabolizing
12
drug-metabolizing enzyme
12
human cyp2as
12

Similar Publications

Tree shrew as a new animal model for musculoskeletal disorders and aging.

Bone Res

January 2025

State Key Laboratory of Organ Failure Research, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.

Intervertebral disc degeneration (IDD), osteoarthritis (OA), and osteoporosis (OP) are common musculoskeletal disorders (MSDs) with similar age-related risk factors, representing the leading causes of disability. However, successful therapeutic development and translation have been hampered by the lack of clinically-relevant animal models. In this study, we investigated the potential suitability of the tree shrew, a small mammal with a close genetic relationship to primates, as a new animal model for MSDs.

View Article and Find Full Text PDF

Cis-Regulatory Evolution of CCNB1IP1 Driving Gradual Increase of Cortical Size and Folding in primates.

bioRxiv

December 2024

Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650201, China.

Neocortex expansion has a concerted relationship with folding, underlying evolution of human cognitive functions. However, molecular mechanisms underlying this significant evolutionary process remains unknown. Here, using tree shrew as an outgroup of primates, we identify a new regulator which acquired its expression before the emergence of primates.

View Article and Find Full Text PDF
Article Synopsis
  • The tree shrew (Tupaia belangeri) is being studied for its similarities to primates, particularly to understand DNA methylation and X chromosome inactivation (XCI) in their brains, using novel genome-wide methylation and transcriptomic data from their prefrontal cortex.
  • The study found that female tree shrews exhibit global hypomethylation of the X chromosome compared to males, but this hypomethylation does not directly cause X chromosome gene silencing or sex-specific gene expression, although it affects the Xist gene's regulation.
  • Overall, the research provides new insights into DNA methylation patterns in tree shrews and suggests that genomic CpG content may influence sex-differential
View Article and Find Full Text PDF

Cellular Characterization and Interspecies Evolution of the Tree Shrew Retina across Postnatal Lifespan.

Research (Wash D C)

November 2024

Department of Anesthesiology, Research Institute of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Tree shrews (TSs) possess a highly developed visual system. Here, we establish an age-related single-cell RNA sequencing atlas of retina cells from 15 TSs, covering 6 major retina cell classes and 3 glial cell types. An age effect is observed on the cell subset composition and gene expression pattern.

View Article and Find Full Text PDF

The number of cationic residues and net charge are critical for the activity of antimicrobial peptides (AMPs) due to their role in facilitating initial electrostatic interactions with negatively charged bacterial membranes. A cathelicidin AMP (TC-33) has been identified from the Chinese tree shrew in our previous work, which exhibited weak antimicrobial activity, likely due to its moderately cationic nature. In the current study, based on TC-33, we designed a novel AMP by peptide truncation and Glu substitutions to increase its net cationic charge from +4 to +8.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!